• By:admin

So-Called Brain Boosting Supplements Found to Contain Harmful Drugs

According to a recent study published in JAMA Internal Medicine, several supplements on the market claiming to boost brain power and offer protection from loss of memory contain various amounts of a dangerous drug known as piracetam.

Piracetam is a drug that has not been approved for use in the United States. It is known to trigger unpleasant side effects such as insomnia, anxiety, agitation, depression, weight gain, drowsiness, and diarrhea. There is also concern for how the drug might affect kidney health, especially in older users.

Many of the people taking piracetam are experiencing negative side effects without realizing they are connected to the supplement.

The US government categorizes supplements – vitamins, minerals, etc. – as food, which makes the restrictions on these products less severe. Supplements do not need to be tested for effectiveness or for safety prior to being sold to the public.

Nootropic Market on the Rise

The market for brain enhancement supplements, also known as nootropics, has increased recently. Some link the increase to the aging of the Baby Boomer generation.

Estimates show American consumers spend more than $600 million a year on these types of supplements, many of whom hope to fend off dementia. Data also shows a big increase in the number of people using nootropics for non-medicinal purposes which is known as Pharmacological Cognitive Enhancement (PCE) and used for improving performance in school and work, among other things.

Unfortunately, at least according to the FDA, nootropics might be ineffective and unsafe. There is also concern that use of these products could prevent someone from seeking proper treatment when there is a problem.

Piracetam, the drug that was found in many of the brain boosting supplements on the market, is prescribed in some European countries to treat cognitive health and other disorders. But some studies have shown that this specific nootropic drug is relatively ineffective and no solid evidence has been found thus far that it offers any brain boosting support at all.

Despite the FDA determining that piracetam could not be sold in the United States as a dietary supplement, the drug is readily available because the supplement market is not that closely managed.

Study Finds Drug Present in Amounts Higher than Recommended for Therapeutic Use

The study that found piracetam in many supplements on the market today was led by Dr. Pieter Cohen of Harvard Medical School. Cohen’s team purchased all of the brands of supplements that were marketed as dietary supplements and included “piracetam” on their labels. The samples they tested contained anywhere from 831 mg to 1542 mg of piracetam per tablet, which would exceed the standard dose of the drug allowed in the countries where piracetam is legally prescribed.

In one case, the amount of piracetam in a single supplement was two to four times higher than the recommended dosage given in countries where its use is legal. And one of the products didn’t even contain piracetam, despite the label claiming it as an ingredient – an issue that indicates how unreliable the supplement market tends to be.

It’s important to note that the study tested only those supplements claiming to contain piracetam, even though it’s assumed that other products likely contain the drug, too. There is also speculation that the amount of piracetam in the products tested could vary from tablet to tablet, as only two samples from each product was tested.

The FDA has issued warning letters concerning the sale or piracetam, but the products containing the drug remain on the market.

Dr. Cohen concluded after the study that until laws are changed concerning the marketing and sale of supplements, those in the medical community should encourage patients to avoid using products that claim to offer cognitive support because there’s a chance they contain “prohibited drugs in supratherapeutic doses.”

Sources:

Related Post

VIEW all
Teva, Major Pharmacies Found Liable for Actions in Opioid Crisis in New York, Ohio
  • By:B. Shaffer

Pharmaceutical manufacturing giant, Teva has been found guilty of its role in the opioid crisis in the state of New York. In a separate ruling in Ohio, major pharmacies Walgreens, CVS and Walmart have been found liable for helping to create an oversupply of drugs leading to the opioid epidemic. The findings are in addition to others reached in federal and other state courts. Teva Found Guilty in State of New York Opioid Crisis A New York jury has ruled …

Opioid Epidemic
Judge Rejects Opioid Lawsuit Settlement for Purdue Pharma’s Sackler Family
  • By:B. Shaffer

A federal judge has rejected Purdue Pharma’s Opioid Lawsuit Settlement agreement releasing the Sackler Family from liability over OxyContin. The agreement had been reached on December 16, 2021, in bankruptcy court and would settle thousands of Opioid lawsuits filed by government agencies and people who had been harmed by OxyContin. Through the bankruptcy court agreement, the Sackler family was to be allowed to pay $4.5 billion to avoid civil liability over their involvement in the Purdue Pharma-OxyContin Opioid lawsuit battles. …

weight loss drug
Weight Loss Drug Removed from Market after Cancer Linked Identified
  • By:B. Shaffer

Eisai, Inc. voluntarily pulled its weight-loss drug Belviq from the market in February 2020 after it was determined that the drug poses a slightly increased risk of cancer. Despite the recall of the product, Eisai said it did not believe the FDA’s interpretation of the latest round of data on the drug’s safety and stated that it still believes the benefits outweigh the risks. According to the FDA, patients currently using Belviq should stop doing so immediately. They should dispose …

Have you been affected by a drug or device listed?